Better Cathie Wood Stock: Moderna vs. Intellia [Yahoo! Finance]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Yahoo! Finance
Wood isn't intimidated by shares that have wallowed in the doldrums because she favors long-term investing. The idea is to buy promising companies for a good price and hold onto the shares for a number of years -- giving those companies time to bring products to market and grow earnings. And that should boost share performance over time. This week, Wood has been adding to her positions in biotech companies Moderna (NASDAQ: MRNA) and Intellia Therapeutics (NASDAQ: NTLA) . Moderna, the maker of a leading coronavirus vaccine, is an expert in mRNA medicine, while Intellia is bringing exciting gene editing candidates through the pipeline. Their shares have dropped 28% and 31%, respectively, over the past year, but Wood clearly sees the long-term potential of these players. Considering this famous investor's expertise in identifying fantastic long-term opportunities, you may want to follow her into these stocks. But if you could only buy one, which makes the better buy right now? The
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at Evercore ISI to a "hold" rating.MarketBeat
- OpenAI's marketing head shares the one big mistake CMOs are making with AI [Yahoo! Finance]Yahoo! Finance
- OpenAI's marketing head shares the one big mistake CMOs are making with AI [Fortune]Fortune
- ProofPilot Celebrates Dual Wins with Moderna at Citeline Awards for Best Patient-Facing Technology & Clinical Partnership of the Year [Yahoo! Finance]Yahoo! Finance
- Moderna, Inc. (NASDAQ: MRNA) is now covered by analysts at Evercore ISI. They set an "in-line" rating and a $120.00 price target on the stock.MarketBeat
MRNA
Earnings
- 5/2/24 - Beat
MRNA
Sec Filings
- 5/15/24 - Form 144
- 5/15/24 - Form 144
- 5/13/24 - Form 4
- MRNA's page on the SEC website